BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Treace Medical Concepts Reports Second Quarter 2023 Financial Results

  Treace Medical Concepts, Inc., a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus through its Lapiplasty® 3D Bunion Correction™ Procedure, reported financial results for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  15 min read
• Business

  Standard BioTools Reports Second Quarter 2023 Financial Results

  Standard BioTools Inc. reported financial results for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  17 min read
• Business

  eFFECTOR Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

  eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors for the treatment of cancer, reported financial results for the second quarter ended June 30, 2023 and provided a corporate update.

  August 8, 2023

   · 

  14 min read
• Business

  Plus Therapeutics to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 14, 2023

  Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult to treat cancers, announced that the Company will report second quarter 2023 financial results on Monday, August 14, 2023, after market close.

  August 8, 2023

   · 

  4 min read
• Business

  Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

  Fate Therapeutics, Inc. reported business highlights and financial results for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  13 min read
• Business

  Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023

  Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today reported financial results and business highlights for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  15 min read
• Business

  Novanta Announces Financial Results for the Second Quarter 2023

  Novanta Inc. today reported financial results for the second quarter 2023.

  August 8, 2023

   · 

  29 min read
• Business

  Verrica Pharmaceuticals Reports Second Quarter 2023 Financial Results

  Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced financial results for the second quarter ended June 30, 2023.

  August 8, 2023

   · 

  13 min read
• Business

  Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call

  Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 15, 2023 to report its second quarter financial results and provide a corporate update.

  August 8, 2023

   · 

  1 min read
• Business

  Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results

  Neuronetics, Inc. today announced its financial and operating results for the second quarter of 2023.

  August 8, 2023

   · 

  14 min read